SCHEMBL5493553

SCHEMBL5493553

C=CCOc1cc(OCC=C)c(C(=O)c2ccc(OCC)cc2)c(C(CC)C(=O)O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
POLB P06746 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
LMNA P02545 1/20 0.40
MAPK1 P28482 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM4E B2RXH2 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
KMT2A Q03164 1/20 0.39
FFAR1 O14842 1/20 0.38
PPARG P37231 1/20 0.37
PPARD Q03181 1/20 0.37
PPARA Q07869 1/20 0.37
ADRB2 P07550 1/20 0.37
ADRB1 P08588 1/20 0.37
ADRB3 P13945 1/20 0.37
ALOX15 P16050 2/20 0.37
PARP10 Q53GL7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2856378 0.93 FLT3 (0.44) MAPTNPC1RAB9APOLBSMN1; SMN2
SCHEMBL2867272 0.92 KDM4E (0.39) MAPTNPC1RAB9APOLBSMN1; SMN2
SCHEMBL2858356 0.91 RAB9A (0.41) MAPTNPC1RAB9APOLBSMN1; SMN2
SCHEMBL6032268 0.90 MAPT (0.49) MAPTNPC1RAB9APOLBSMN1; SMN2
SCHEMBL2862952 0.86 KDM4E (0.36) MAPTNPC1RAB9APOLBSMN1; SMN2
SCHEMBL2860150 0.86 KDM4E (0.46) RAB9APOLBKDM4ENPSR1KMT2A
SCHEMBL2865481 0.85 KDM4E (0.45) MAPTNPC1RAB9APOLBSMN1; SMN2
SCHEMBL2858839 0.85 ALDH1A1 (0.38) MAPTNPC1RAB9APOLBSMN1; SMN2
SCHEMBL2858288 0.83 FLT3 (0.43) MAPTNPC1RAB9APOLBSMN1; SMN2
SCHEMBL2866472 0.82 ALDH1A1 (0.37) MAPTNPC1RAB9APOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070032532-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-02-08 US disclosed
EP-1642880-A1 HSP90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-04-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032532-A1 Hsp90 family protein inhibitors HSP90AB1, HSP90B1, HSP90AB2P MAPT 1791/4885NPC1 1079/4885RAB9A 1598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.